Multiple myeloma affects many systems in the body, including the bones, blood, kidneys, and immune system. The symptoms that may have sent you to the doctor in the first place, such as back or leg ...

Drs Joseph Mikhael and Peter Voorhees discuss considerations for treating smoldering multiple myeloma, including recent ...

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

The Food and Drug Administration granted fast track designation to HDP-101 for the treatment of multiple myeloma. The U.S.

Shock is a common initial reaction to a cancer diagnosis, especially when it contrasts with family health history. Hospital environments and medical procedures can heighten anxiety, but compassionate ...

The antibody-drug conjugate, withdrawn from the market by GSK in 2022 after failing a confirmatory study, was approved ...

The new approval completes a surprise turnaround for Blenrep, which was initially cleared in 2020 but pulled from the market ...

It is hoped it will allow medics to better understand how cancer cells are behaving before planning treatment.

SWIFT-seq uses single-cell sequencing to profile CTCs, offering a noninvasive alternative to bone marrow biopsies for MM diagnosis and monitoring. The method provides comprehensive genomic and ...

Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, the second most common type of blood cancer. In multiple ...